Drug Shortage Report for HAVRIX 1440
Report ID | 70161 |
Drug Identification Number | 02187078 |
Brand name | HAVRIX - SUS IM 1440 ELISA UNITS/ML |
Common or Proper name | hepatitis A vaccine, inactivated |
Company Name | GLAXOSMITHKLINE INC |
Market Status | MARKETED |
Active Ingredient(s) | HEPATITIS A VACCINE, INACTIVATED |
Strength(s) | 1440UNIT |
Dosage form(s) | SUSPENSION |
Route of administration | INTRAMUSCULAR |
Packaging size | 1's (prefilled syringe / seringue préremplie) |
ATC code | J07BC |
ATC description | VIRAL VACCINES |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2018-12-18 |
Estimated end date | 2019-02-04 |
Actual end date | 2019-01-18 |
Shortage status | Resolved |
Updated date | 2019-01-19 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2019-01-19 | English | Compare |
v4 | 2019-01-18 | French | Compare |
v3 | 2019-01-18 | English | Compare |
v2 | 2018-12-20 | French | Compare |
v1 | 2018-12-20 | English | Compare |
Showing 1 to 5 of 5